GE offers off-the-shelf manufacturing plants; Valeant, Medicis combine operations;

> GE Healthcare is now selling what it calls KUBio, an off-the-shelf, 1,200-square-meter modular factory that can be quickly erected and ready to manufacture. Story

> GeneTex, the U.S. antibody producer, says it will make a new antibody against HIF1a (hypoxia-inducible factor 1alpha) that is more stable than many on the market. Item

> Under new rules in Denmark, drug manufacturers' authorization to do business will not have to be updated but will be considered valid unless regulators take steps to change them. Story

> Valeant Pharmaceuticals ($VRX) is buying dermatology specialist Medicis Pharmaceuticals for $2.6 billion. Story

And Finally... More than 50 years after its morning sickness drug Thalidomide was banned because it causes deformities in children whose mothers took it, the German drugmaker Grunenthal has apologized for its effects. Story

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.